Evidence map›Paper›PMID 38264644›Full record

ArticleFrontiers in immunology2023

Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencing.

Haleigh E Conley, Max M He, David Easterhoff, Hélène Fradin Kirshner, Sarah L Cocklin, Jacob Meyer, Taylor Hoxie, Madison Berry, Todd Bradley, William D Tolbert and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Haleigh E ConleyDepartment of Surgery, Duke University School of Medicine, Duke University, Durham, NC, United States.
Max M HeDuke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
David EasterhoffDuke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Hélène Fradin KirshnerDuke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Sarah L CocklinCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Jacob MeyerDuke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Taylor HoxieDuke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Madison BerryDuke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Todd BradleyGenomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO, United States.
William D TolbertInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Marzena PazgierInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Georgia D TomarasDepartment of Surgery, Duke University School of Medicine, Duke University, Durham, NC, United States.
Joern E SchmitzCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Michael Anthony Moody *Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Kevin Wiehe *Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Justin Pollara *Department of Surgery, Duke University School of Medicine, Duke University, Durham, NC, United States.
Duke University · USBeth Israel Deaconess Medical Center · USUniformed Services University of the Health Sciences · USChildren's Mercy Hospital · US

Funding

Virus and Antibody Gene Sequencing CoreP01AI131251 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Kevin Wiehe · 2017 to 2026
$40.7M
Structure-Function Analytics CoreP01AI162242 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2021 to 2025
$22.2M
Physical Resources CoreP01AI120756 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2016 to 2020
$17.1M
Ruth L. Kirschstein National Research Service Award (NRSA)- T32T32AI007392 · NIAID · DUKE UNIVERSITY · PI Amy Lynn Corneli, Guido Ferrari · 1990 to 2026
$9.8M
NIAID NIH HHS P01 AI120756NIAID NIH HHS P01 AI131251NIAID NIH HHS P01 AI162242NIAID NIH HHS T32 AI007392
6 · The paper itself

Abstract

Fcγ receptors (FcγRs) are membrane-bound glycoproteins that bind to the fragment crystallizable (Fc) constant regions of IgG antibodies. Interactions between IgG immune complexes and FcγRs can initiate signal transduction that mediates important components of the immune response including activation of immune cells for clearance of opsonized pathogens or infected host cells. In humans, many studies have identified associations between FcγR gene polymorphisms and risk of infection, or progression of disease, suggesting a gene-level impact on FcγR-dependent immune responses. Rhesus macaques are an important translational model for most human health interventions, yet little is known about the breadth of rhesus macaque FcγR genetic diversity. This lack of knowledge prevents evaluation of the impact of FcγR polymorphisms on outcomes of preclinical studies performed in rhesus macaques. In this study we used long-read RNA sequencing to define the genetic diversity of FcγRs in 206 Indian-origin Rhesus macaques,

Indexed as

Antigen-Antibody ComplexReceptors, IgGAnimalsFrameshift MutationHumansImmunoglobulin GMacaca mulattaMembrane GlycoproteinsSequence Analysis, RNAAntigen-Antibody ComplexImmunoglobulin GMembrane GlycoproteinsReceptors, IgGFc receptorFcγR SNPsFcγR structuresgenetic diversityLong-read RNA sequencingrhesus macaques

Identifiers

PMID38264644
PMCPMC10803544
OpenAlexW4390750444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.